Leading The Way In Pediatric Endo-Cannabinoid Medicine

Phyto Therapeutic Medicine for Inflammatory Conditions

Initial 2.2 Million Square Feet of Cultivation

Exclusive Clinically Validated Formulations

Innovation in Skin Care and Anti-Aging Systems

Relevium’s CEO Provides an Open Shareholder Letter for 2020

MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio...

Relevium Launches LeefyLyfe™ Organic Hemp Products in the US

MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness...

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract...

Relevium Technologies

Relevium is a publicly traded corporation strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector. Our focus is on being a trusted source of high-quality nutraceutical and CBD products.

Subscribe to our Newsletter

You have Successfully Subscribed!